Meet RIKO, Built From Seven Years of Pharma Decisions
HRV Pharma has launched RIKO, which it describes as India's first AI native pharmaceutical operating system. The idea came from inside the company, and so did the build.
Built on Real Pharmaceutical Decisions
What sets RIKO apart is what it learned from. Instead of public data, it draws on millions of real decisions made across HRV's network of 50+ FDA and EU GMP certified partners and customers in 55 countries, over more than seven years.
AI-Powered Pharmaceutical Decision-Making
Ten federated reasoning models weigh chemistry risk, nitrosamine potential, supplier reliability, regulatory history and market signals together, before a sourcing or licensing decision is made. Partners get a quicker path through qualification. Customers see the risks before they commit.
Building Institutional Intelligence
As Hari Kiran Chereddi puts it, technology can be copied and capacity can be added. Institutional intelligence takes years to build, and he believes it will decide who leads the industry next.
Featured in Chronicle Pharmabiz
Read the full article on Chronicle Pharmabiz
https://www.pharmabiz.com/NewsDetails.aspx?aid=187197&sid=2
